Robert Besser
04 Dec 2022, 08:04 GMT+10
WASHINGTON D.C.: According to trial data contained in a report presented this week, an experimental Alzheimer's drug from Eisai and Biogen, lecanemab, slowed cognitive decline, but could cause serious side effects for certain patients.
In the 18-month trial involving nearly 1,800 participants with early-stage Alzheimer's, Lecanemab was possibly the cause of a dangerous type of brain swelling in nearly 13 percent of patients.
Five patients also suffered from macrohemorrhages and 14 percent from microhemorrhages, which could have caused two deaths in a follow-on study.
In September, the two companies said that lecanemab, an antibody designed to remove sticky deposits of a protein called amyloid beta, reduced the rate of cognitive decline on a clinical dementia scale (CDR-SB) by 27 percent, compared to a placebo.
However, Dr. Ronald Petersen of the Mayo Clinic in Rochester, Minnesota said, "All of these amyloid-lowering drugs carry a risk for increased brain hemorrhage."
The data confirms the drug "can meaningfully change the course of the disease," said the Alzheimer's Association, calling on U.S. regulators to approve the company's application for accelerated approval.
Detailed data from the study was presented at the Clinical Trials on Alzheimer's Disease meeting in San Francisco.
The U.S. Food and Drug Administration (FDA) will decide whether to approve lecanemab under its "accelerated" review program by 6th January. However, Eisai will soon file for standard FDA approval of the drug and will also seek approval in Europe and Japan, regardless of the FDA's decision.
Get a daily dose of Nigeria Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Nigeria Sun.
More InformationTOKYO, Japan: In light of a tense security environment following Russia's invasion of Ukraine and Moscow's growing military cooperation with ...
DALLAS, Texas: Oil and gas pipeline operators are preparing to stockpile equipment following severe weather forecasts for the next few ...
WASHINGTON D.C.: As US lawmakers investigate the Chinese-owned video-sharing app TikTok, its Chief Executive, Shou Zi Chew, has confirmed that ...
TEHRAN, Iran: A gunman this week stormed the Azerbaijan Embassy in the Iranian capital, Tehran, and killed its security chief ...
WASHINGTON, DC - FBI agents on Wednesday searched for classified documents at U.S. President Joe Biden's vacation retreat in the ...
WASHINGTON D.C.: The White House said this week that Tesla Chief Executive Elon Musk met with John Podesta, a Democratic ...
TRIPOLI, Libya: Italian prime minister Giorgia Meloni held talks on energy and migration in Libya this weekend, which are major ...
Hank Lebioda piled up nine birdies to shoot an 8-under-par 63 and take the first-round lead at the ATT Pebble ...
juba, south sudan - The embassies of Britain, Norway, and the United States have expressed grave concerns about possible new ...
On the third day of his trip to Africa, Pope Francis told leaders of the Catholic Church in the Democratic ...
Blantyre, Malawi - Malawi has suspended the head of its Anti-Corruption Bureau over a leaked audio clip that where she ...
Patrick Mahomes didn't mince words on Thursday when asked about the importance of having two Black quarterbacks start a Super ...